Assignee profile
Jiangsu Hengrui Medicine
Coverage of patents, compounds and activity records linked to this assignee.
2 patents8 compounds28 activity records
Summary
AssigneeJiangsu Hengrui Medicine
Filing years2021-2022
Patents2
Compounds8
Activity records28
Patent families2
Targets1
Assay familiesdegradation, viability
Activity metricsIC50, cell_viability, degradation
Overview
Target distribution and active-compound trend
Target distribution
28 activity records
Active compounds by publication year
Distinct compounds linked to assignee patent publications
Activity compounds and values